Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Pharmacology & Toxicology|December 29, 2000
MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in ratsJ Jolkkonen, R Kauppinen, L Nyman, et al.Epilepsia|January 1, 1993
Vigabatrin (gamma-vinyl-GABA): neuropathologic evaluation in five patientsJ Sivenius, L Paljärvi, M Vapalahti, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2000
Delirium episode as a sign of undetected dementia among community dwelling elderly subjects: a 2 year follow up studyT Rahkonen, R Luukkainen-Markkula, S Paanila, et al.Epilepsia|January 1, 1989
Specificity of vigabatrin for the GABAergic system in human epilepsyP J Riekkinen, A Pitkanen, A Ylinen, et al.Stroke|March 1, 1985
The incidence of stroke in the Kuopio area of East FinlandJ Sivenius, O P Heinonen, K Pyörälä, et al.Annals of Clinical Research|April 1, 1982
Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapyV Hoikka, K Savolainen, P Karjalainen, et al.British Journal of Clinical Pharmacology|January 1, 1989
Cerebrospinal fluid GABA and seizure control with vigabatrinP J Riekkinen, A Ylinen, T Halonen, et al.Acta Neurologica Scandinavica|February 1, 1993
European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderlyJ Sivenius, P J Riekkinen, M Laakso, et al.Archives of Neurology|July 1, 1993
Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic eventJ Sivenius, P J Riekkinen, A Lowenthal, et al.Annals of Neurology|June 1, 1991
The European Stroke Prevention Study (ESPS): results by arterial distributionJ Sivenius, P J Riekkinen, P Smets, et al.Pageof 11